首页> 外文期刊>Journal of cardiothoracic and vascular anesthesia >Atrial fibrillation after aortic arch repair requiring deep hypothermic circulatory arrest: incidence, clinical outcome, and clinical predictors.
【24h】

Atrial fibrillation after aortic arch repair requiring deep hypothermic circulatory arrest: incidence, clinical outcome, and clinical predictors.

机译:主动脉弓修复后的房颤,需要进行深低温循环性停搏:发生率,临床结果和临床预测指标。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

OBJECTIVE: To delineate the incidence, outcome impact, and clinical predictors of atrial fibrillation (AF) after adult aortic arch repair requiring deep hypothermic circulatory arrest (AAR-DHCA) AIMS: To determine the incidence of AF after AAR-DHCA, to determine whether AF after AAR-DHCA affects mortality or stay in the intensive care unit (ICU), to determine multivariate predictors for AF after AAR-DHCA, and to determine whether aprotinin protects against AF after AAR-DHCA. STUDY DESIGN: Retrospective and observational. STUDY SETTING: Single large university hospital. PARTICIPANTS: All adults undergoing AAR-DHCA in 2000 and 2001. MAIN RESULTS: The cohort size was 144. Antifibrinolytic exposure was 100%, aprotinin 66% and aminocaproic acid 34%. The incidence of AF was 34.0%. AF was not significantly associated with increased mortality or prolonged ICU stay. Advanced age was a multivariate risk factor for AF. Lower temperature nadir during DHCA was protective against postoperative AF. Aprotinin had no demonstrable effect on AF after AAR-DHCA. CONCLUSIONS: AF after AAR-DHCA is common but does not independently increase mortality or ICU stay. The risk of AF after AAR-DHCA increases with age but decreases with the degree of hypothermia during DHCA. Aprotinin does not appear to affect the risk of AF after AAR-DHCA.
机译:目的:描述需要深低温循环停止(AAR-DHCA)的成人主动脉弓修复后房颤(AF)的发生率,预后影响和临床预测指标。目的:确定AAR-DHCA后AF的发生率,以确定是否AAR-DHCA后的房颤会影响死亡率或留在重症监护病房(ICU),以确定AAR-DHCA后房颤的多变量预测因子,并确定抑肽酶是否能预防AAR-DHCA后房颤。研究设计:回顾性和观察性。研究机构:一家大型大学医院。参与者:2000年和2001年接受AAR-DHCA治疗的所有成年人。主要结果:队列规模为144人。抗纤溶药物暴露率为100%,抑肽酶为66%,氨基己酸为34%。 AF的发生率为34.0%。 AF与死亡率增加或ICU停留时间延长没有显着相关。高龄是房颤的多因素危险因素。 DHCA期间的最低温度降低可预防术后房颤。抑肽酶对AAR-DHCA后的房颤无明显作用。结论:AAR-DHCA后发生房颤很常见,但并不能独立增加死亡率或重症监护病房。 AAR-DHCA后发生房颤的风险随着年龄的增长而增加,但随着DHCA过程中体温降低的程度而降低。抑肽酶似乎不影响AAR-DHCA后发生房颤的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号